Fundz

Axial Therapeutics reported raising $27.4 Million in an initial SEC Form D filing, from an offering of $24 Million

PRIVATEOct 27, 2023

Amount Raised

$27.4 Million

$27.4 Million sold, per SEC Form D (first sale Oct 18, 2023)

Round Type

Venture

WoburnBiotechnologyHealthcareHealth Care

Quick answer

Axial Therapeutics raised $27.4 Million in a funding round, dated October 18, 2023. Axial Therapeutics is based in Woburn, Massachusetts, United States.

How much did Axial Therapeutics raise?
Axial Therapeutics raised $27.4 Million in a funding round on October 18, 2023.
What does Axial Therapeutics do?
Axial Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases.
Where is Axial Therapeutics based and how big is it?
Axial Therapeutics is based in Woburn, Massachusetts, United States. Fundz records about 12 employees.
Who are the decision-makers at Axial Therapeutics?
Fundz holds 2 contacts at Axial Therapeutics, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Axial Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • INTRINSIC THERAPEUTICS raised $55M on November 30, 2023.
  • Tenon Medical raised $1.3M (Seed) on November 21, 2023.
  • Route 92 Medical raised $31M (Series F) on November 16, 2023.
  • Greenbrook TMS raised $2.5M (Seed) on November 16, 2023.
  • Route 92 Medical raised $31M on November 15, 2023.
  • ReAlta Life Sciences raised $30M on November 7, 2023.

Who to call at Axial Therapeutics, and when

A new round usually means Axial Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Axial Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Axial Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Axial Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Axial Therapeutics

Location

400 TRADECENTER DRIVE, SUITE 6990

Woburn, Massachusetts, United States

About

Axial Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases. The company is the scientific leader in the biological role of the microbiome gut-brain axis and its influence on the central nervous system. Harnessing its unique expertise in the microbiome, Axial is developing small molecule drugs with defined mechanisms of action that act on new targets to mitigate the impact of metabolites and bacteria in the gut linked to neurological disease pathology, progression, and symptoms. The company is advancing a pipeline of microbiome-inspired therapeutics for diseases with significant unmet patient need, including autism and Parkinson’s disease, and is also pursuing pre-clinical discovery of gut-targeted therapies in oncology. Axial’s lead product candidate is AB-2004, a molecular therapeutic in Phase 2 clinical trials for the treatment of irritability in children with autism.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Axial Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsA. Stewart C., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Axial Therapeutics's next move

See what Strategic adds

Axial Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.